4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001501697-26-000065
Chief Financial Officer sold 8,543 shares at $4.26 ($36,428)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KIRSKE DAVID Chief Financial Officer | 2026-06-30 | Sale | −8,543 | $4.26 | $36,428 | 167,750 | D |
| Open-market sales · 8,543 sh · avg $4.26 · $36,428 | |||||||
Loading xslF345X06/wk-form4_1782937402.xml…